176 related articles for article (PubMed ID: 36691316)
21. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
[TBL] [Abstract][Full Text] [Related]
22. Molecular epidemiology of human papillomavirus 18 infections in Japanese Women.
Yamaguchi-Naka M; Onuki M; Tenjimbayashi Y; Hirose Y; Tasaka N; Satoh T; Morisada T; Iwata T; Sekizawa A; Matsumoto K; Kukimoto I
Infect Genet Evol; 2020 Sep; 83():104345. PubMed ID: 32360473
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix.
Vosmik M; Laco J; Sirak I; Beranek M; Hovorkova E; Vosmikova H; Drastikova M; Hodek M; Zoul Z; Odrazka K; Petera J
Pathol Oncol Res; 2014 Jan; 20(1):131-7. PubMed ID: 23913252
[TBL] [Abstract][Full Text] [Related]
24. Whole-exome and RNA sequencing reveal novel insights into the pathogenesis of HPV associated cervical cancer.
Wu Y; Zhao J; Dong S; Wang Y; Li A; Jiang Y; Chen Z; Li C; Wang W; Zhang Z
Cancer Biomark; 2019; 25(4):341-350. PubMed ID: 31306105
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.
Huang L; Lin JX; Yu YH; Zhang MY; Wang HY; Zheng M
PLoS One; 2012; 7(3):e33762. PubMed ID: 22438992
[TBL] [Abstract][Full Text] [Related]
26. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers.
Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T
Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134
[TBL] [Abstract][Full Text] [Related]
27. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
[TBL] [Abstract][Full Text] [Related]
28. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E
BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281
[TBL] [Abstract][Full Text] [Related]
29. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
Geraets D; Alemany L; Guimera N; de Sanjose S; de Koning M; Molijn A; Jenkins D; Bosch X; Quint W;
J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
[TBL] [Abstract][Full Text] [Related]
30. Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: A descriptive study in invasive cervical cancer.
Brant AC; Menezes AN; Felix SP; de Almeida LM; Sammeth M; Moreira MAM
Genomics; 2019 Dec; 111(6):1853-1861. PubMed ID: 30552977
[TBL] [Abstract][Full Text] [Related]
31. Expression of the c-myc oncogene and the presence of HPV 18: possible surrogate markers for cervical cancer?
Rughooputh S; Manraj S; Eddoo R; Greenwell P
Br J Biomed Sci; 2009; 66(2):74-8. PubMed ID: 19637647
[TBL] [Abstract][Full Text] [Related]
32. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
[TBL] [Abstract][Full Text] [Related]
33. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
[TBL] [Abstract][Full Text] [Related]
34. Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells.
Vazquez-Ortiz G; García JA; Ciudad CJ; Noé V; Peñuelas S; López-Romero R; Mendoza-Lorenzo P; Piña-Sánchez P; Salcedo M
Int J Gynecol Cancer; 2007; 17(2):484-91. PubMed ID: 17309674
[TBL] [Abstract][Full Text] [Related]
35. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.
Ferber MJ; Eilers P; Schuuring E; Fenton JA; Fleuren GJ; Kenter G; Szuhai K; Smith DI; Raap AK; Brink AA
Cancer Genet Cytogenet; 2004 Oct; 154(1):1-9. PubMed ID: 15381365
[TBL] [Abstract][Full Text] [Related]
36. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
37. Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer.
Huang B; Zhu L; Wei H; Shi H; Zhang D; Yuan H; Luan L; Zheng N; Xu S; Nawaz W; Hong Y; Wu X; Wu Z
Front Immunol; 2021; 12():678318. PubMed ID: 34248960
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
39. Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea : Korean HPV18 variants and clinical manifestation.
Kim N; Park JS; Kim JE; Park JH; Park H; Roh EY; Yoon JH; Shin S
Virol J; 2020 May; 17(1):70. PubMed ID: 32448303
[TBL] [Abstract][Full Text] [Related]
40. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
